Vitamin D Deficiency (Severe-Rickets)MANAGEMENT

ENDOCRINE AND METABOLIC PRESENTATIONS · 12 SECTIONS

⚲

426 items

☷ Legend

⚲

Cardiovascular Presentations71▾

Respiratory Presentations52▾

Neurological Presentations83▾

Gastrointestinal Presentations74▾

Genitourinary and Reproductive Presentations48▾

Infectious Disease Presentations148▾

Trauma Presentations89▾

Toxicologic Presentations80▾

Psychiatric Presentations26▾

Musculoskeletal and Rheumatologic Presentations96▾

Dermatology Presentations23▾

Environmental and Exposure Presentations27▾

Hematologic and Oncologic Presentations36▾

Pediatric-Specific Presentations19▾

Endocrine and Metabolic Presentations45▾

Acute Porphyria Adrenal crisis Adrenal Insufficiency (Addisonian Crisis)Dehydration Diabetes Insipidus Diabetic Ketoacidosis (DKA)Euglycemic DKA (SGLT2 inhibitor)Galactosemia GLP-1 receptor agonist complications (retained gastric contents, aspiration risk)Homocystinuria Hypercalcemia Hyperkalemia Hypermagnesemia Hypernatremia Hyperosmolar Hyperglycemic State (HHS)Hypertensive emergency Hypertensive urgency Hypocalcemia Hypoglycemia Hypogonadism (Acute Presentation)Hypokalemia Hypomagnesemia Hyponatremia Hypoparathyroidism (Tetany)Insulin pump failure Maple Syrup Urine Disease (Crisis)Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)Metabolic Acidosis Metabolic Alkalosis Myasthenia gravis crisis Myxedema coma Pellagra Pheochromocytoma (Crisis)Pituitary Apoplexy Pompe Disease (GSD II)Respiratory Acidosis Respiratory Alkalosis Scurvy SIADH Starvation Ketosis Tarui Disease (GSD VII)Thyroid storm Tyrosinemia Vitamin D Deficiency (Severe-Rickets)Von Gierke Disease (GSD I)

ENT and Maxillofacial Presentations27▾

Ophthalmologic Presentations19▾

Obstetric Presentations23▾

Systemic and Miscellaneous Presentations17▾

01Approach to the Critical Patient/attcp16

Immediate Stabilization

›Life-threatening presentations requiring immediate intervention

›Hypocalcemic seizure — IV calcium gluconate first-line; do not use anticonvulsants

›Anticonvulsants may worsen hypocalcemia and are contraindicated for hypocalcemic seizures

›Laryngospasm — airway management priority; IV calcium gluconate urgently

›Dilated cardiomyopathy or cardiogenic shock in infants — cardiac support and immediate calcium repletion

›Prolonged QT interval — continuous cardiac monitoring; risk of torsades de pointes

Resuscitation Priorities

›Initial priorities in the critically ill patient

›Airway protection if laryngospasm or altered mental status

›IV access and continuous cardiac monitoring (12-lead ECG)

›Point-of-care ionized calcium immediately

›Escalate to resuscitation bay for hemodynamic instability or active seizure

Key Decision Points

›Critical decision branch points

›Symptomatic hypocalcemia (seizure, tetany, laryngospasm) — IV calcium regardless of 25-OHD level

›Ionized calcium below 0.8 mmol/L — IV calcium gluconate even if asymptomatic

›Suspected cardiomyopathy — emergent echocardiography and cardiology consultation

›If genetic rickets suspected (failure to respond, positive family history) — pediatric endocrinology consult

02History/hx56

Chief Complaint and HPI

›Presenting symptoms and timeline

›Bone pain — location and duration

›Limb deformity — progressive bowing of legs

›Difficulty walking or waddling gait

›Seizure — focal or generalized; may be presenting symptom

›Muscle weakness — proximal distribution

›Irritability or lethargy in infants

›Poor feeding in infants

›Growth failure or short stature

›Insidious onset typical; skeletal deformities worsen during rapid growth phases

Timing and Triggers

›Temporal patterns and exacerbating factors

›Peak symptom onset between 3 and 18 months in children

›Winter months exacerbate deficiency due to reduced UV exposure

›Adolescence — second period of rapid growth and high risk

›Adults — vague diffuse musculoskeletal aches and proximal weakness

Associated Symptoms

›Additional symptom review

›Tetany — muscle cramps, carpopedal spasm, paresthesias

›Recurrent respiratory infections — associated with severe deficiency in infancy

›Dental abnormalities — delayed dentition, enamel hypoplasia

›Failure to thrive

›Delayed motor milestones

›Dyspnea or poor feeding — cardiac involvement

Dietary History

›Nutritional intake and supplementation

›Exclusive breastfeeding without vitamin D supplementation — breast milk contains only 15 to 50 IU/L

03Physical Exam/exam33

Vital Signs

›Hemodynamic and respiratory parameters

›Tachycardia — may indicate heart failure or pain

›Tachypnea — respiratory compromise from cardiac involvement or skeletal deformity

›Hypotension — cardiogenic shock in severe infantile cases

›Fever — evaluate for concurrent infection

Head and Neck Examination

›Cranial and facial findings

›Craniotabes — ping-pong ball sensation on palpation of posterior skull; indicates severe prolonged deficiency in neonates

›Frontal bossing — prominent forehead

›Delayed fontanelle closure

›Dental enamel hypoplasia and delayed dentition

›Chvostek sign — facial muscle twitch with tapping of facial nerve anterior to ear; indicates hypocalcemia

Chest Examination

›Thoracic skeletal findings

›Rachitic rosary — palpable beading at costochondral junctions

›Harrison sulcus — horizontal groove at diaphragm attachment

›Pigeon chest or pectus carinatum deformity

›Auscultation for heart failure signs — gallop rhythm, crackles

Extremity and Skeletal Examination

›Limb and skeletal deformities

›Widened and swollen wrists — metaphyseal widening

›Widened and swollen ankles

›Genu varum — bow legs

›Genu valgum — knock knees

›Waddling gait

›Pathologic fracture sites

04Differential Diagnosis/ddx22

Nutritional and Metabolic Causes

›Common nutritional causes of rickets

›Nutritional rickets — vitamin D and/or calcium deficiency — most common cause worldwide

›ICD-10: E55.0 Rickets, active

›Calcium-deficiency rickets — normal 25-OHD, low dietary calcium, high PTH

›Osteomalacia in adults — same mechanisms as rickets but at completed growth plate

›ICD-10: M83.9 Adult osteomalacia, unspecified

Genetic and Hereditary Rickets

›Monogenic causes requiring specific treatment

›X-linked hypophosphatemia — most common genetic cause; PHEX mutation; elevated FGF23; low phosphate; normal calcium

›ICD-10: E83.31 Familial hypophosphatemia

›Vitamin D-dependent rickets type 1A — CYP27B1 mutation; low calcitriol; responds to calcitriol replacement

›Vitamin D-dependent rickets type 2 — VDR mutation; end-organ resistance; often with alopecia

›Hypophosphatasia — low alkaline phosphatase; ALPL mutation; mimics rickets on X-ray

Renal and Systemic Causes

›Organ-dysfunction-related bone disease

›Renal osteodystrophy — chronic kidney disease with impaired 1,25(OH)2D production

›ICD-10: N25.0 Renal osteodystrophy

›Fanconi syndrome or renal tubular acidosis — phosphate wasting, metabolic acidosis

›Tumor-induced osteomalacia — FGF23-secreting mesenchymal tumor; rare in children

Life-Threatening Mimics

›High-stakes diagnoses not to miss

›Non-accidental injury (child abuse) — must be considered in infants with fractures; rickets is a recognized differential per AAP 2025 guidance

›Hypoparathyroidism — hypocalcemia with low PTH; normal 25-OHD

›Pseudohypoparathyroidism — PTH resistance; low calcium, high PTH

›Primary hyperparathyroidism with secondary skeletal changes

05Laboratory Tests/lt26

First-Line Serum Tests

›Essential serum tests for all suspected cases

›25-hydroxyvitamin D (25-OHD) — gold standard for vitamin D status

›Severe deficiency: below 30 nmol/L (below 12 ng/mL)

›Insufficiency: 30 to 50 nmol/L

›Sufficient: above 50 nmol/L

›Ionized calcium — most clinically actionable; below 0.8 mmol/L indicates IV repletion

›Total calcium — adjusted for albumin; hypocalcemia threshold below 2.1 mmol/L

›Phosphate — low in nutritional rickets and XLH; normal or high in hypoparathyroidism

›Alkaline phosphatase — markedly elevated in active rickets; low in hypophosphatasia

›Parathyroid hormone — elevated (secondary hyperparathyroidism) in nutritional rickets

Extended Biochemical Panel

›Additional serum studies for characterization

›1,25-dihydroxyvitamin D — low in VDDR type 1A; high in VDDR type 2; not first-line for nutritional rickets

›Magnesium — hypomagnesemia potentiates hypocalcemia and impairs PTH secretion

›Albumin — needed to interpret total calcium; calculate corrected calcium

›Creatinine and eGFR — renal osteodystrophy evaluation

›Liver function tests — hepatic vitamin D metabolism assessment

›FGF23 — elevated in XLH and tumor-induced osteomalacia; send if phosphate is persistently low

›Uric acid and amino acids — if Fanconi syndrome suspected

Urinary Tests

›Urine studies for phosphate handling

›Urine phosphate and creatinine — for tubular maximum phosphate reabsorption (TmP/GFR) calculation

›Urine calcium to creatinine ratio — hypercalciuria suggests vitamin D toxicity or genetic hypercalciuria

›Urine amino acids — positive in Fanconi syndrome

Point-of-Care Testing

›Bedside tests for immediate management

›Point-of-care ionized calcium — immediate result to guide IV calcium administration

06Diagnostic Tests/dt46

Scoring Systems

›Clinical criteria and diagnostic scoring

›Global Consensus Recommendations on Prevention and Management of Nutritional Rickets (2016)

›Diagnostic criteria: active rickets confirmed by elevated ALP plus low 25-OHD or low calcium or low phosphate

›Radiographic confirmation recommended when biochemistry is equivocal

›Uday and Hogler Diagnostic Criteria for Osteomalacia (2019)

›Clinical scoring: bone pain plus proximal weakness plus low 25-OHD

›Sensitivity and specificity of clinical criteria alone not well established; biochemical confirmation required

›Three-stage classification of nutritional rickets severity

›Stage 1: Biochemical abnormality only; no radiographic changes

›Stage 2: Radiographic changes present; no fractures or deformity

›Stage 3: Fractures, deformity, or skeletal complications present

MRI

›MRI indications and findings

›MRI of extremities

›Not routinely indicated for uncomplicated nutritional rickets

›May demonstrate physeal widening and growth plate abnormalities

›Useful if tumor-induced osteomalacia suspected — whole-body MRI to localize FGF23-secreting tumors

›MRI brain — if seizure with focal features or concern for intracranial pathology

›Not required for typical hypocalcemic seizures once calcium confirmed as cause

›Basal ganglia calcification may be seen on MRI in chronic hypocalcemia

›CT indications in rickets

›CT of thorax or abdomen

›Low utility for uncomplicated nutritional rickets

›CT chest if pulmonary cause of vitamin D malabsorption or if respiratory compromise

›CT bone densitometry (quantitative CT)

›Provides volumetric bone mineral density; more sensitive than DXA for trabecular bone loss

07Disposition/dispo25

Admission Criteria

›Indications for hospital admission

›Active hypocalcemic seizure or status epilepticus

›Laryngospasm or stridor

›Dilated cardiomyopathy or heart failure

›Prolonged QTc above 500 ms or ventricular arrhythmia

›Ionized calcium below 0.8 mmol/L regardless of symptoms

›Inability to tolerate oral intake

›Pathologic fracture requiring orthopedic management

›Severe systemic illness concurrent with vitamin D deficiency

Observation Criteria

›Patients suitable for observation or short-stay

›Moderate hypocalcemia (total calcium 1.75 to 2.1 mmol/L) without symptoms

›Reliable family and reliable oral calcium and vitamin D supplementation

›Biochemical abnormalities improving after initial IV calcium

Discharge Criteria

›Conditions required for safe discharge

›Asymptomatic with mild biochemical abnormalities only

›Able to take oral medications reliably

›Calcium above 2.1 mmol/L and ionized calcium above 1.0 mmol/L

›Confirmed reliable follow-up within 2 to 4 weeks

›Return precautions clearly communicated to family

Specialist Consultations

›Subspecialty referral indications

›Pediatric endocrinology — failure to respond to treatment; suspected genetic rickets

›Orthopedics — severe skeletal deformity; pathologic fracture

›Cardiology — cardiomyopathy; persistent arrhythmia

›Nephrology — renal osteodystrophy or Fanconi syndrome

08Treatment/t45

Acute IV Calcium Repletion

›IV calcium for symptomatic or severe hypocalcemia

›Calcium gluconate 10% solution — first-line agent

›Acute seizure or tetany: 0.5 to 1.0 mL/kg IV over 5 to 10 minutes (maximum 20 mL per dose)

›Continuous cardiac monitoring during infusion; can cause bradycardia

›Maintenance infusion after acute dose: 0.5 to 1.5 mmol/kg/day as continuous infusion

›Titrate to normalize ionized calcium

›Reassess ionized calcium every 4 to 6 hours during infusion

›Calcium chloride 10% solution — alternative; more caustic; prefer central line or large bore IV

›Contains 3 times more elemental calcium per mL than gluconate

›Monitor for extravasation — calcium gluconate causes tissue necrosis if extravasated

Oral Calcium Supplementation

›Calcium replacement during treatment phase

›Calcium carbonate or calcium citrate — preferred oral formulations

›Children aged 1 to 3 years: 500 mg elemental calcium per day in divided doses

›Children aged 4 to 8 years: 800 mg elemental calcium per day

›Children aged 9 to 18 years: 1000 to 1300 mg elemental calcium per day

›Adults: 1000 to 1200 mg elemental calcium per day

›Adequate calcium intake essential alongside vitamin D replacement throughout treatment course

Vitamin D Replacement

›Cholecalciferol (D3) — preferred over ergocalciferol (D2)

›Standard treatment dose for nutritional rickets in children

›Daily oral regimen: 2000 to 6000 IU per day for 12 weeks

›Higher end of range for children with malabsorption or dark pigmentation

›High-dose intermittent (stoss) regimen: 150,000 to 600,000 IU as single oral or IM dose

›Reserved for non-adherent patients or those unable to take daily therapy

›Clinical Endocrinology RCT 2024: daily and fortnightly regimens showed equivalent biochemical outcomes

›Maintenance after treatment completion

09Special Populations/sp45

Pregnancy

›Vitamin D deficiency in pregnancy

›Prevalence and risk

›Maternal vitamin D deficiency directly causes neonatal deficiency and congenital rickets

›Dark-skinned women, veiled women, and those in high-latitude regions at highest risk

›Diagnosis and thresholds in pregnancy

›25-OHD below 30 nmol/L — severe deficiency; treat promptly

›Same diagnostic thresholds as non-pregnant adults; PTH elevated in deficiency

›Treatment in pregnancy

›Cholecalciferol 1500 to 2000 IU per day throughout pregnancy — standard recommendation

›Higher doses (4000 IU per day) considered in severely deficient or high-risk pregnant women

›Calcium supplementation 1000 mg per day alongside vitamin D

›Neonatal considerations

›All breastfed infants of deficient mothers require 400 IU per day from birth

›Neonatal hypocalcemic seizures may occur within first 2 weeks if maternal deficiency is severe

Geriatric

›Vitamin D deficiency in older adults

›Epidemiology and risk

›Reduced cutaneous synthesis with aging — 70-year-olds produce 75% less vitamin D than young adults under same UV exposure

›Institutionalized elderly have near-universal deficiency; increased fall and fracture risk

›Clinical presentation differences

›Osteomalacia more common than frank rickets; proximal myopathy; diffuse bone pain

›Falls and fragility fractures — primary clinical consequence in geriatric population

›Treatment in older adults

›Cholecalciferol 1500 to 2000 IU per day; higher doses if baseline 25-OHD below 30 nmol/L

›Calcium 1200 mg per day; calcium carbonate with meals; calcium citrate if achlorhydria

›Avoid calcium doses above 500 mg at one time — impairs absorption

›Monitor for hypercalcemia and renal stones in those with comorbidities

10Background/b40

Epidemiology

›Prevalence, incidence, and distribution

›Global burden

›Nutritional rickets affects children in every region; highest burden in Africa, Middle East, and South Asia

›Estimated global prevalence up to 7.5 per 1000 children in high-risk regions

›Severe vitamin D deficiency (25-OHD below 30 nmol/L) affects 5 to 15% of infants in developed countries

›High-risk demographic groups

›Dark-skinned exclusively breastfed infants without supplementation — highest risk group in developed countries

›Immigrant and refugee children from sun-rich to sun-poor countries

›Institutionalized or housebound individuals

›Hypocalcemic seizure incidence: 3.49 per million children aged 0 to 15 years (Neurology 2020)

›Cardiac complications

›Dilated cardiomyopathy is a recognized nutritional heart disease associated with severe deficiency

›Exact incidence of cardiac complications from vitamin D deficiency not precisely established

Pathophysiology

›Mechanisms of disease

›Vitamin D metabolism pathway

›Skin synthesis: 7-dehydrocholesterol converted to cholecalciferol under UVB

›Hepatic 25-hydroxylation: cholecalciferol to 25-OHD (calcidiol) — storage form

›Renal 1-alpha-hydroxylation: 25-OHD to 1,25(OH)2D (calcitriol) — active form

›CYP27B1 encodes renal 1-alpha-hydroxylase; CYP3A4 catalyzes hepatic catabolism

›Consequences of deficiency

›Low calcitriol reduces intestinal calcium and phosphate absorption

›Secondary hyperparathyroidism — PTH rises to maintain serum calcium; increases bone resorption and phosphate wasting

›Defective mineralization of osteoid — rickets at growth plate in children; osteomalacia in adults

›Cardiac effects — hypocalcemia causes prolonged QT, cardiomyopathy, and heart failure

›Drug-induced catabolism

›Anticonvulsants and rifampin induce CYP3A4 — accelerate hepatic catabolism of 25-OHD to inactive metabolites

11Patient Discharge Instructions/pdi30

copy discharge instructions

›Discharge instructions for patient and family

›Diagnosis explanation

›Your child has been diagnosed with severe vitamin D deficiency (rickets)

›Vitamin D is needed for healthy bones; without it, bones become soft and can bend or break

›Prescribed medications

›Take vitamin D (cholecalciferol) drops or tablets exactly as prescribed every day

›Take calcium supplement with meals as directed

›Do not skip doses; consistent daily use is required for bone healing

›Dietary guidance

›Include vitamin D-rich foods: oily fish (salmon, mackerel), fortified milk, fortified cereals, egg yolks

›Include calcium-rich foods: dairy products, fortified plant milks, leafy greens, tofu

›Breastfed infants need vitamin D drops starting from birth; do not stop unless directed by your doctor

›Sun exposure guidance

›Safe outdoor sun exposure is beneficial; aim for short periods without full sunscreen coverage when safe

›Avoid prolonged unprotected sun exposure; consult your doctor about safe practices

›Activity restrictions

›Protect the child from falls; bones may be fragile during healing

›Avoid contact sports or high-impact activity until cleared by your doctor

›Follow-up appointments

›Blood test appointment in 2 to 4 weeks to check calcium, phosphate, and vitamin D levels

›Clinic appointment with your family doctor or specialist in 2 to 4 weeks

›X-ray of wrists and knees will be arranged at approximately 3 months to check bone healing

›Return to emergency department immediately if

›Seizure or convulsion occurs

›Muscle spasms, twitching, or hands and feet cramping

›Difficulty breathing, noisy breathing, or stridor

›Your child becomes very lethargic, limp, or difficult to wake

12References/r42

Guidelines and Key Sources

›Primary clinical guidelines and landmark references

›Cochrane Database Systematic Reviews 2020 — Chibuzor MT et al. Vitamin D, calcium or combination for nutritional rickets in children

›Cochrane Library doi:10.1002/14651858.CD012581.pub2

›Cochrane Database Systematic Reviews 2020 — Tan ML et al. Vitamin D supplementation for term breastfed infants

›Cochrane Library doi:10.1002/14651858.CD013046.pub2

›Pediatric Nephrology 2022 — Haffner D et al. Rickets Guidance Part I: Diagnostic Workup

›PMID 34910242

›Lancet 2014 — Elder CJ, Bishop NJ. Rickets

›PMID 24412049

›Lancet 2003 — Wharton B, Bishop N. Rickets

›PMID 14585642

›Lancet 2024 — Kamenicky P et al. X-Linked Hypophosphataemia

›PMID 39181153

›Indian Journal of Medical Research 2020 — Uday S, Hogler W. Nutritional Rickets and Osteomalacia: A Practical Approach

›PMID 33380700

›JAMA Pediatrics 2023 — Gharibeh N et al. Vitamin D supplementation and bone mass in infants with 25-OHD below 50 nmol/L

›doi:10.1001/jamapediatrics.2022.5837

Supporting Evidence

›Additional key references

›Neurology 2020 — Monni R et al. Focal hypocalcemic seizures secondary to severe vitamin D deficiency/rickets

›PMID 32546651

›Journal of the American College of Cardiology 2022 — Sliwa K et al. Nutritional heart disease and cardiomyopathies

›PMID 36599756

›Clinical Endocrinology 2024 — Mondal KAP et al. Daily versus fortnightly oral vitamin D3 in symptomatic deficiency

›doi:10.1111/cen.15124

›Nutrients 2018 — Cesareo R et al. AME/AACE Position Statement: Clinical management of vitamin D deficiency in adults

›PMC5986426

Learn More: Vitamin D Deficiency (Severe-Rickets)→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.